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REVIEW
Prevention of relapse in patients with congestive
heart failure: the role of precipitating factors
J Feenstra, D E Grobbee, F A M Jonkman, A W Hoes, B H Ch Stricker
Abstract
Relapse of congestive heart failure (CHF)
frequently occurs and has serious conse-
quences in terms of morbidity, mortality,
and health care expenditure. Many studies
have investigated the aetiological and
prognostic factors of CHF, but there are
only limited data on the role of precipitat-
ing factors that trigger relapse of CHF.
Knowledge of potential precipitating fac-
tors may help to optimise treatment and
provide guidance for patients with CHF.
The literature was reviewed to identify
factors that may influence haemodynamic
homeostasis in CHF. Precipitating factors
that may oVer opportunities for prevent-
ing relapse of CHF were selected. Poten-
tial precipitating factors are discussed in
relation to the pathophysiology of CHF:
alcohol, smoking, psychological stress,
uncontrolled hypertension, cardiac ar-
rhythmias, myocardial ischaemia, poor
treatment compliance, and inappropriate
medical treatment. Poor treatment com-
pliance in particular is frequently encoun-
tered in patients with CHF. Furthermore,
studies of medical treatment under every-
day circumstances indicate that some
aspects of the management of CHF can be
improved. In conclusion, the identifica-
tion of precipitating factors for relapse of
CHF may strongly contribute to optimal
treatment. Improvement of treatment
compliance and optimalisation of medical
treatment may oVer important possibili-
ties to clinicians to reduce the number of
relapses in patients with CHF.
(Heart 1998;80:432–436)
Keywords: congestive heart failure; precipitating
factors; prevention
There is increasing interest in congestive heart
failure (CHF) from both clinicians and re-
searchers. The prevalence of CHF continues to
increase despite advances in the treatment of
various risk factors for this disease, such as
hypertension and coronary artery disease.1
This increase is the result of several medical
and demographic developments: an aging
population, decreasing mortality of patients
with acute myocardial infarction, and im-
proved treatment of patients with angina
pectoris and hypertension.2 In addition, sur-
vival in patients with CHF has improved since
the introduction of angiotensin converting
enzyme (ACE) inhibitors.
CHF is clinically characterised by periods of
remission and exacerbation. Readmission rates
of up to 25% within six months after a previous
hospital discharge for CHF have been reported
in patients older than 65 years.3 4 Relapse of
CHF in patients with previously stable com-
pensated heart failure may be caused by
deteriorating ventricular function, but several
precipitating factors have been suggested.5 6
Some precipitating factors can be regarded as
potentially preventable. Research on precipi-
tating factors leading to relapses of CHF, how-
ever, is scarce.5 6 Nevertheless, timely identifi-
cation of potential precipitating factors may
oVer an important advantage in eVorts to
reduce morbidity and the number of hospital
admissions attributed to the syndrome of CHF.
We conducted a search of the MEDLINE data-
base from 1966 to December 1997 and used
lateral references to review the literature on
potential precipitating factors. In this article we
focus on the role of precipitating factors that
are relatively common in clinical practice and
potentially modifiable: the eVects of alcohol,
smoking, psychological stress, uncontrolled
hypertension, cardiac arrhythmias, myocardial
ischaemia, lack of compliance, and inappropri-
ate medical treatment.
Precipitating factors for relapse of
congestive heart failure
Knowledge of potential precipitating factors for
relapse of CHF is crucial to prevent or postpone
such relapses. In a descriptive study, Ghali et al5
examined potential precipitating factors in 101
hospital readmissions for CHF. Precipitating
factors were identified in 93% of patients. The
most common factor was lack of adherence to
the prescribed medical regimen (64% of pa-
tients). Other frequently identified precipitating
factors were uncontrolled hypertension (44%),
cardiac arrhythmias (29%), iatrogenic factors
(21%), and pulmonary infection (17%) (table
1). In a more recent study, Opasich et al6 identi-
fied precipitating factors in 91% of 328 in-
stances of non-fatal decompensation in 304
patients. All patients had a history of at least one
previous episode of severe decompensation.
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Common precipitating factors were cardiac
arrhythmias (24% of patients), poor compliance
(15%), infection (23%), angina pectoris (14%),
and iatrogenic factors (10%). Frequency diVer-
ences in specific precipitating factors reflect the
diVerent populations and designs of the two
studies. In addition, the absence of a control
group excludes assessment of the relative risk of
these potential precipitating factors.
Several diseases may induce the syndrome of
CHF. Patients in whom CHF is diagnosed
should be given optimal medical care to
prevent clinical worsening while maintaining
quality of life. An accurate evaluation of poten-
tial precipitating factors should also be rou-
tinely performed in patients with relapse of
CHF.
The haemodynamic eVects of these precipi-
tating factors are discussed within the frame-
work of current views on the pathophysiology
of CHF. Apart from the precipitating factors
discussed here, CHF may also be precipitated
by infection, anaemia, pulmonary embolism,
thyroid disease, pregnancy, and physical, di-
etary, fluid, and environmental excesses.5–7 As
most of these factors have either known causes,
such as excessive salt intake and excessive
intravenous fluid administration, or relatively
uncommon causes, they are not discussed in
further detail.
ALCOHOL
CHF resulting from alcoholic cardiomyopathy
is a relatively common cause of non-ischaemic
cardiomyopathy.8 The amount and duration of
alcohol consumption required to induce alco-
holic cardiomyopathy is not well defined, but
has been estimated at five to six ounces
(1 oz = 28 ml) of ethanol daily for at least 10
years. Abstention from alcohol is crucial in
patients with alcohol induced cardiomyopathy.9
Echocardiographic studies show that major
clinical improvement and normalisation of left
ventricular function can be achieved after
abstention from alcohol.10 11 Resumed alcohol
intake may be a precipitating factor for relapse
of CHF.
There is no convincing evidence for absolute
abstention from alcohol in patients with CHF
not induced by alcohol. In a study in which the
acute eVects of moderate alcohol consumption
(0.9 g/kg) in patients with New York Heart
Association (NYHA) class III–IV heart failure
were assessed, small but significant reductions
in arterial pressure, pulmonary artery pressure,
pulmonary artery wedge pressure, and sys-
temic vascular resistance were seen after a sin-
gle dose of alcohol, but CHF did not
deteriorate.12 Chronic heavy alcohol consump-
tion should be strongly discouraged in all
patients with CHF, but there are no convincing
reasons to warn against incidental moderate
consumption of alcohol.13 Clinical practice
shows, however, that some patients with appar-
ently non-alcoholic induced CHF may have
significant improvement after complete absten-
tion from even incidental moderate alcohol
consumption. Therefore, evaluation of a period
of complete alcohol abstention in patients with
severe CHF may be worthwhile.
SMOKING
Several studies have been performed on the
acute haemodynamic eVects of smoking. Ciga-
rette smoking increases heart rate and blood
pressure, both principal determinants of myo-
cardial oxygen consumption.14 Goldbarg et al
showed in healthy individuals that the left ven-
tricular stroke index decreased significantly at
several levels of exercise after smoking, al-
though there was no significant change at rest.15
Aronow et al investigated the eVects of cigarette
smoking and breathing carbon monoxide on
cardiovascular haemodynamics in patients with
angina.16 This study showed that an increased
level of carboxyhaemoglobin had a negative
inotropic eVect and increased left ventricular
end diastolic pressure. There was a significant
decrease in the stroke index after smoking.
Pentecost et al indicated that cigarette smoking
tends to decrease cardiac output especially in
older patients with a history of myocardial
infarction.17 Nicolozakes et al investigated the
eVects of smoking in patients with NYHA class
III CHF.18 Cardiac output remained un-
changed after smoking, but other haemody-
namic changes were seen. As expected, heart
rate and systemic blood pressure (double
product) increased substantially after smoking.
In addition, there were mild increases in
pulmonary artery pressure, ventricular filling
pressures, and total systemic and pulmonary
vascular resistance. The increased ventricular
afterload probably accounts for the observed
mild decrease in stroke volume. Thus smoking
increases oxygen demand but decreases myo-
cardial oxygen supply because of reduced
diastolic filling time and increased carboxyhae-
moglobin level. This finding has important
negative consequences for myocardial oxygen
supply. Patients with CHF should be strongly
advised to stop smoking and informed that
continued smoking can unfavourably aVect
CHF. It remains unclear to what extent smok-
ing may act as a precipitating factor for relapse
of CHF.
PSYCHOLOGICAL STRESS
Mental stress in patients with ischaemic heart
disease can induce transient myocardial ischae-
mia and transient wall motion abnormalities.19
Rozanski et al reported that wall motion abnor-
malities occurred in 59% of patients with coron-
ary artery disease during mental stress.20 A drop
in ejection fraction of more than 5% was seen in
Table 1 Factors that may precipitate relapses in patients
with pre-existing CHF
Lack of treatment compliance
Myocardial infarction
Angina pectoris or painless myocardial ischaemia
Alcohol consumption
Cardiac arrhythmias
Inappropriate medical treatment
Infections
Anaemia
Pulmonary embolism
Thyroid disease
Pregnancy
Physical, dietary, fluid, and environmental excesses
Emotional stress
Systemic hypertension
Smoking
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36% of patients. Wall motion abnormalities were
seen in only 8% of normal controls during men-
tal stress. There was no clear eVect on ejection
fraction in the controls. Mental stress may also
induce transient changes of the electrophysi-
ological properties of the myocardium, which
may sensitise the heart to life threatening
ventricular arrhythmias.21 Emotional factors
preceding hospitalisation for CHF have been
reported in 49% of patients.7 Stress induced
heart failure has been described.22 Giannuzzi et
al reported that psychological stress induced
changes in left ventricular diastolic function in
patients with idiopathic cardiomyopathy.19 The
eVects of mental arithmetic on these patients
were compared with those on controls. The ratio
of transmitral peak flow velocity in early versus
late diastole significantly increased during men-
tal arithmetic, while transmitral deceleration
time greatly decreased. These findings suggest
that left ventricular function is impaired during
psychological stress. Neuroendocrine activation
and a significant increase in arterial blood press-
ure may also contribute to the haemodynamic
eVects of psychological stress.
The full eVects of psychological stress on
cardiovascular function in patients with CHF
are not known, but many of the discussed
eVects may be considered unfavourable.
UNCONTROLLED HYPERTENSION
Recent data from the Framingham study
underscore the importance of hypertension as
a major risk factor for CHF.23 Hypertension
may impair ventricular function by increasing
afterload and impairing systolic contraction
and diastolic relaxation.24 Approximately 50%
of patients with hypertension and a normal
coronary angiogram have transient ST seg-
ment depression during 24 hour Holter moni-
toring, usually without angina pectoris.25 As
there is no relation with left ventricular hyper-
trophy, these findings reflect a disturbed
coronary microvasculature. Intervention trials
have provided convincing evidence of the
eYcacy of hypertension treatment in reducing
the incidence of CHF.26 Obviously, persistent
hypertension in patients with CHF will have a
detrimental eVect on ventricular performance.
Blood pressure in patients with end stage CHF
usually decreases because of low cardiac
output. Uncontrolled hypertension despite
antihypertensive treatment, defined as diastolic
blood pressure of 105 mm Hg or more, was
identified in 44% of patients readmitted to
hospital for CHF.5 Adequate blood pressure
control in patients with CHF is crucial because
of the numerous haemodynamic eVects of
hypertension, although there are few data on
the extent to which uncontrolled hypertension
may account for relapse of CHF.
ARRHYTHMIAS
Cardiac arrhythmias are frequently present in
patients with CHF and are regarded as a sign of
impaired left ventricular function. Atrial fibril-
lation is the most prevalent cardiac arrhythmia
in patients with CHF. Nevertheless, its prog-
nostic significance is controversial. There have
been studies in which atrial fibrillation did not
increase morbidity and mortality as well as
studies in which atrial fibrillation was a marker
for an increased mortality risk.27 28 Ghali et al
reported that cardiac arrhythmias, particularly
atrial fibrillation, were present in 29% of
patients studied and were considered to be
directly responsible for relapse of CHF in 78%
of patients.5 Cardioversion of chronic atrial
fibrillation to sinus rhythm in patients with
NYHA functional class I or II significantly
increased cardiac output during exercise,
maximum oxygen uptake, and maximal toler-
ated workload.29 Successful cardioversion in
patients with chronic atrial fibrillation and
idiopathic dilated cardiomyopathy significantly
improved left ventricular ejection fraction from
32% to 53%.30 Several studies have reported on
patients with severe left ventricular dysfunction
and atrial fibrillation with rapid ventricular
response.31 32 Left ventricular dysfunction in
these patients may be completely reversed by
controlling ventricular rate or restoring sinus
rhythm. The unfavourable haemodynamic
consequences of atrial fibrillation compared
with those of sinus rhythm suggest that
development of this arrhythmia may be a trig-
ger for relapse of CHF.
MYOCARDIAL ISCHAEMIA
The detrimental eVects of myocardial ischae-
mia on ventricular function have been well
documented.33 The main cause of progressive
myocardial failure is postulated as subendocar-
dial ischaemia, even in patients with non-
ischaemic CHF.34 Silent or symptomatic myo-
cardial ischaemia can also be identified as part
of the pathway relating other potential precipi-
tating factors, such as psychological stress,
smoking, cardiac arrhythmias, and hyper-
tension, to relapses of CHF.25 35 Impairment of
systolic and diastolic ventricular function
persists from hours to days after transient myo-
cardial ischaemia.36 Hibernating myocardium
is a widely accepted concept in modern cardi-
ology, defined as a state of persistently
impaired myocardial and left ventricular func-
tion at rest because of reduced coronary blood
flow.33 Hibernating myocardium can be consid-
ered as a myocardial adaptation to reduced
coronary blood flow, to prevent irreversible
myocardial damage. The significant improve-
ment of left ventricular function after coronary
revascularisation is mainly based on this
principle.33 Although the exact frequency of
hibernating myocardium is not known, Carlson
et al reported hibernating myocardium in 75%
of patients with unstable angina pectoris and in
25% of patients with stable angina pectoris.37
Abolition of myocardial hibernation can im-
prove left ventricular function.33 Therefore,
prevention of myocardial ischaemia may con-
tribute to the maintenance of haemodynamic
homeostasis in patients with CHF.
LACK OF TREATMENT COMPLIANCE
Non-compliance to medication and diet has
repeatedly been identified as a frequent pre-
cipitating factor for admission to hospital for
decompensated heart failure.5 6 Moreover, sev-
eral studies have reported approximately 50%
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non-compliance with long term medication
regimens.38 This may represent an important
impediment to eVective treatment of CHF.
Interestingly, physicians’ personal characteris-
tics and characteristics of their practices also
influence patients’ adherence to medical
treatment.39 Physicians’ global job satisfaction
positively influences patient compliance.
Non-compliance deserves major attention
from health professionals, as it may oVer an
opportunity to make a significant contribution
to preventing relapse in patients with CHF.
INAPPROPRIATE MEDICAL TREATMENT
Iatrogenic factors responsible for relapses of
CHF were identified by Ghali et al in 21% of
relapses5 and by Opaschi et al in 10% of
relapses.6 The most important causes of
iatrogenic CHF are usually inappropriate
medication and excessive intravenous fluid
administration. Although not discussed in
detail here, several categories of drugs, such as
non-steroidal anti-inflammatory drugs, â
blockers, and antiarrhythmics, may aVect
cardiovascular homeostasis, especially in pa-
tients with pre-existing left ventricular impair-
ment. Rich et al prospectively studied the
occurrence of iatrogenic CHF in 401 patients
hospitalised for CHF.40 CHF was considered
iatrogenic in 28 (7%) patients. As a result of the
inability of the researchers to reliably assess
causality between suspected inadequate medi-
cation and the onset of CHF, most instances of
iatrogenic CHF were attributed to excessive
intravenous fluid administration. Therefore,
the importance of inappropriate medication,
such as withdrawal of ACE inhibitors, seems to
have been underestimated in this study.
Patients with CHF deserve optimal treat-
ment and investigation. However, some studies
have reported flaws in the management of
CHF. Clarke et al carried out a retrospective
study in six general practices of 505 patients
given loop diuretics.41 Seventy four per cent of
281 patients who fulfilled diagnostic criteria for
CHF were referred to hospital, but only one
third had echocardiography. Furthermore, 234
of 281 patients who fulfilled diagnostic criteria
for CHF were not treated with ACE inhibitors.
Among them were 26 patients with docu-
mented evidence of left ventricular impair-
ment. These findings strongly suggest short-
comings in the diagnosis and treatment of
CHF, but lack of information on the severity of
CHF in this study makes it diYcult to draw
definite conclusions. Hillis et al reported in a
review of the case notes of 343 patients
discharged from hospital with a diagnosis of
CHF that only 40% of patients received ACE
inhibitors.42 Of patients with NYHA class III
and IV CHF, only 50% were treated with ACE
inhibitors at the time of discharge from hospi-
tal. Although retrospective studies may have
methodological limitations, they clearly high-
light some aspects of the management of CHF
that need to be improved.
Prevention of iatrogenic CHF should be a
major issue in optimising medical treatment in
these patients.
Conclusions
Relapse in patients with CHF is the result of
deteriorating underlying cardiac disease. Clini-
cal practice and observational studies, how-
ever, have shown that precipitating factors can
be identified in many patients with increased
symptoms of CHF. These precipitating factors
may have contributed to or even induced
symptoms of CHF. Few studies have investi-
gated these precipitating factors despite their
presence in relapse of CHF. Suboptimal medi-
cal treatment and poor patient compliance in
particular deserve more attention, as these fac-
tors can be considered as potentially prevent-
able determinants of relapse of CHF.
Most of the discussed factors are common in
daily practice, but little is known about their
influence on cardiac performance in patients
with CHF under everyday circumstances.
Most studies on the haemodynamic eVects of
smoking, alcohol, or psychological stress have
been laboratory experiments. Such findings do
not always reflect the eVects in clinical practice.
Despite these limitations the negative haemo-
dynamic eVects of most precipitating factors
discussed here are suYcient for them to be
considered as unfavourable. Therefore, the
presence of potential precipitating factors as
listed in the table 1 should be routinely evalu-
ated in patients presenting with CHF. Elimina-
tion of these precipitating factors, if possible,
may contribute to the prevention of relapse in
patients with CHF.
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